Prolonged converting enzyme inhibition following captopril in patients with renal insuffficiency [letter]
Authors:
- Bc CampbellBCBc Campbell
- An ShepherdASAn Shepherd
- Hl ElliottHEHl Elliott
- K McLeanKMK McLean
- Jl ReidJRJl Reid
Open Access
- 1 May 1982
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 13 (5) , 755-757
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Effects of the angiotensin converting enzyme inhibitor, captopril, in essential hypertension.British Journal of Clinical Pharmacology, 1982
- Blood concentration and urinary excretion of captopril (SQ 14,225) in patients with chronic renal failure.Hypertension, 1981
- Opposite Effects of Captopril on Angiotensin I-Converting Enzyme ‘Activity’ and ‘Concentration’; Relation between Enzyme Inhibition and Long-Term Blood Pressure ResponseClinical Science, 1981
- Active Transport of Sodium and Potassium IonsNew England Journal of Medicine, 1980
- The Measurement of Angiotensin-Converting Enzyme in Subjects Receiving CaptoprilNew England Journal of Medicine, 1980
- CAPTOPRIL IN THE TREATMENT OF CLINICAL HYPERTENSION AND CARDIAC FAILUREThe Lancet, 1979
- A liquid chromatography-assisted assay for angiotensin-converting enzyme (peptidyl dipeptidase) in serum.Clinical Chemistry, 1979
- A sensitive radioenzymatic assay for norepinephrine in tissues and plasmaLife Sciences, 1975